Literature DB >> 4979052

Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition.

A J Glazko.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4979052

Source DB:  PubMed          Journal:  Ann Phys Med        ISSN: 0365-5547


× No keyword cloud information.
  7 in total

1.  Biotransformations of glafenine in the rat and in man.

Authors:  J Pottier; M Busigny; J P Raynaud
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

2.  Characterization of the acyl-adenylate linked metabolite of mefenamic Acid.

Authors:  Howard Horng; Leslie Z Benet
Journal:  Chem Res Toxicol       Date:  2013-02-26       Impact factor: 3.739

3.  The effect of charcoal on mefenamic acid elimination.

Authors:  E M Allen; D C Buss; J Williams; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

4.  Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium.

Authors:  G J Sanger; A Bennett
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

5.  Identification and characterization of mefloquine efficacy against JC virus in vitro.

Authors:  Margot Brickelmaier; Alexey Lugovskoy; Ramya Kartikeyan; Marta M Reviriego-Mendoza; Norm Allaire; Kenneth Simon; Richard J Frisque; Leonid Gorelik
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

6.  The nonenzymatic reactivity of the acyl-linked metabolites of mefenamic acid toward amino and thiol functional group bionucleophiles.

Authors:  Howard Horng; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2013-08-23       Impact factor: 3.922

7.  Simultaneous analysis of 14 non-steroidal anti-inflammatory drugs in human serum by electrospray ionization-tandem mass spectrometry without chromatography.

Authors:  J de Kanel; W E Vickery; F X Diamond
Journal:  J Am Soc Mass Spectrom       Date:  1998-03       Impact factor: 3.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.